Friday 19^th November 2010

13:30      Welcome and introduction (D. Betticher, Fribourg)

13:35      Head/neck and lung tumor (D. Betticher, Fribourg)

Personalizing therapy and today’s best clinical practices in head/neck and lung cancer

13:45      Current best clinical practices using systemic therapy for treating head/neck tumor (M. Pless, Winterthur)

14:15      Current best clinical practices using systemic therapy for treating NSCLC (R. Stahel, Zürich)

14:45      Case presentation and electronic voting: first line therapy+maintenance (Electronic voting) (D. Betticher, Fribourg)

14:55      Maintenance Therapy in NSCLC – PRO (R. Stahel, Zürich)

15:05      Maintenance Therapy in NSCLC – CONTRA (Electronic voting) (S. Peters, Lausanne)

15:15      Coffee break

NSCLC - a pot of different diseases

15:45      Histologies and molecular biologies: routine practice and new developments (L. Bubendorf, Basel)

16:15      Predictive factors for head/neck and lung cancer: ripe for clinical use? (O. Gautschi, Bern)

16:45      Therapy based on the alteration of the EGFR gene and response to therapy, today’s standard (N. Thatcher, Manchester)

17:15      Targeted therapies beyond the EGFR gene mutation (E. Felip, Barcelona)

17:45      Round table, case presentations by the attendees, discussion (O. Gautschi, Bern/M. Pless, Winterthur/D. Betticher, Fribourg)

18:30      Adjourn

Saturday 20^th November 2010

Therapies in head/neck cancer

08:00      Concomitant radio-chemotherapy in head and neck cancer (A. Allal, Fribourg)

08:30      Targeted therapies in head and neck cancer (J. B. Vermorken, Brussels)

09:00      Case presentation: large head/neck tumor, induction chemotherapy with/without radiotherapy? (Electronic voting) (D. Betticher, Fribourg)

09:10      Induction chemo-radiotherapy – CONTRA (A. Allal, Fribourg)

09:20      Induction chemo-radiotherapy – PRO (Electronic voting) (J. B. Vermorken, Brussels)

09:30      Coffee break

Localized NSCLC and head/neck tumor – which is the best therapy

10:00      Importance of multidisciplinarity in the therapy of lung and head/neck tumors (W. Weder, Zürich)

10:30      Neoadjuvant combined therapy in localized NSCLC (S. Peters, Lausanne)

11:00      Adjuvant radiotherapy in radical resected NSCLC and Head and neck tumor (M. Ozsahin, Lausanne)

11:30      Case presentation: small peripheral adenocarcinoma in a patient with poor lung function (Electronic voting) (D. Betticher, Fribourg)

11:40      Segmentectomy – YES (W. Weder, Zürich)

11:50      Radio-surgery – YES (Electronic voting) (M. Ozsahin, Lausane)

12:00      Lunch

New developments in NSCLC and head/neck tumors

13:00      What if resistant to TKI in patients with EGFR mutated tumors (E. Felip, Barcelona)

13:30      New targeted therapies in head/neck tumors, current studies, hopes for the future (J. B. Vermorken, Brussels)

14:00      New targeted therapies in NSCLC, current studies, hopes for the future (N. Thatcher, Manchester)

14:30      Wrap-up and conclusions (D. Betticher, Fribourg)